Edge Therapeutics, Inc.

CLOSED

211 Warren St, 新泽西州联合县, New Jersey, United Statesedgetherapeutics.comPublic1–10 employeesEstablished: 2009-01-01

Part of PDS Biotechnology

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2009

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (7)

A clinical trial to compare the investigational drug EG-1962 with standard of care oral nimodipine in adults with Subarachnoid Hemorrhage caused by a ruptured aneurysm.

Phase 1

Active, not recruiting

Dec 2016374 participants

An international clinical study to compare a new investigational (not yetapproved) treatment called EG-1962 to compare against the currentstandard of care, oral Nimodipine, for the improvement of symptoms youmay experience after a brain hemorrhage.

Phase 1

Active, not recruiting

Sep 2016374 participants

An international clinical study to compare a new investigational (not yetapproved) treatment called EG-1962 to compare against the currentstandard of care, oral Nimodipine, for the improvement of symptoms youmay experience after a brain hemorrhage.

Phase 1

Active, not recruiting

Sep 2016374 participants

An international clinical study to compare a new investigational (not yet approved) treatment called EG-1962 to compare against the current standard of care, oral nimodipine, for the improvement of symptoms you may experience after a brain hemorrhage

Phase 1

Active, not recruiting

Sep 2016374 participants

A clinical trial to compare the investigational drug EG-1962 with standard of care oral nimodipine in adults with Subarachnoid Hemorrhage caused by a ruptured aneurysm.

Phase 1

Active, not recruiting

Sep 2016282 participants

MULTICENTER, CONTROLLED, DOSE ESCALATION, SAFETY, TOLERABILITY STUDY COMPARING EG-1962 AND NIMODIPINE IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

Phase 1

Active, not recruiting

Nov 201496 participants

MULTICENTER, CONTROLLED, DOSE ESCALATION, SAFETY, TOLERABILITY STUDY COMPARING EG-1962 AND NIMODIPINE IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

Phase 1

Active, not recruiting

Nov 201496 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations